# Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules Containing Memantine Hydrochloride in Healthy Adults

> **NCT03711825** · EARLY_PHASE1 · COMPLETED · sponsor: **Lyndra Inc.** · enrollment: 8 (actual)

## Conditions studied

- Alzheimer Disease
- Gastric Retention
- Healthy

## Interventions

- **DRUG:** LYN-057
- **PROCEDURE:** Imaging Assessment (MRI)
- **PROCEDURE:** Imaging Assessment (U/S)

## Key facts

- **NCT ID:** NCT03711825
- **Lead sponsor:** Lyndra Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-10
- **Primary completion:** 2018-10-01
- **Final completion:** 2018-11-13
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2019-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03711825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03711825, "Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules Containing Memantine Hydrochloride in Healthy Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03711825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*